LUMBY, BC, Sept. 1 /PRNewswire-FirstCall/ - avVaa World Health Care Products Inc. (Pink Sheets: AVVH), a global biotechnology company, manufacturer and distributor of nationally branded therapeutic, natural skin and health care products, announced that it has successfully completed its first week of DRTV 120/60 second test commercials for Neuroskin(R) Psoriasis Relief.
Lorie Campbell-Farley, President and COO of avVaa World Health Care Products Inc. stated, "Our first week of testing was to establish that all of our systems are up and running, and that our vendors are prepared for a full sales roll-out."
The DRTV commercials rolled promptly on August 24th, and customers began purchasing the same day. The test showed that Synergixx, the inbound call center, and 3PL, the fulfillment center, are exceeding expectations. "They are working together seamlessly," commented Mrs. Campbell-Farley.
The test also successfully resolved a problem with payment processing. Web orders through MyNeuroskin.com initially would not process, forcing customers to call the 1-800 number in order to purchase. The problem was resolved on August 31, allowing customers to place online orders.
With all initial problems resolved, 13 DRTV 120/60 second commercials are scheduled to run this week. "Once we have all the initial data in, we will release the full results," stated Mrs. Campbell-Farley.
About avVaa World Health Care Products
avVaa World Health Care Products is a global biotechnology company that specializes in effective, all natural, therapeutic skin care products that improve quality of life and well being for consumers. avVaa's patented European skin care formulas are scientifically registered, FDA-Compliant, and were developed to relieve and treat the symptoms of common skin ailments, including eczema, psoriasis and acne. avVaa is poised to manufacture and market its OTC Neuroskin(R)) line of skin care products th
|SOURCE avVaa World Health Care Products|
Copyright©2009 PR Newswire.
All rights reserved